Restoring Independence to Millions.
First European implantable BCI company with FDA-approved* clinical trial in the US.
*FDA approval under an Investigational Device Exemption (IDE)
The first fully implantable system that learns and adapts.
Continuous neural data streaming enables AI-powered therapy optimization in real-time, with seamless wireless communication across all system components.
The Brain Interchange System is an investigational device and is not approved for commercial use. CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use.
FDA Breakthrough Device Designation
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for CorTec’s Brain Interchange™ system. The designation covers the use of direct cortical electrical stimulation to support motor recovery in people living with chronic stroke-related impairments.
Stronger Motor Recovery in 6 Weeks Than in the Entire Previous Year
Observed in first study participant. Investigational device.
Therapeutic Effect Persists After Stimulation Stops
Observed in first study participant. Investigational device.
Stable Wireless Operation for 6+ Months
Observed in first study participant. Investigational device.
Fully Customizable Closed-Loop BCI with 32 Channels
CorTec’s BCI platform combines real-time signal processing with targeted brain stimulation through 32 implanted channels. Our closed-loop system continuously monitors neural activity and adapts stimulation parameters in milliseconds – enabling precise, responsive treatment.
Ready to Shape the Future of Neurotechnology?
CorTec is preparing its next funding round to accelerate pivotal trials, expand indications, and drive toward commercialization. We welcome conversations with aligned investors.
Disclaimer: This page may contain forward‑looking statements subject to risks and uncertainties. Actual results may differ materially. No investment advice. No obligation to update unless required by law (Section 85 WpHG).
$400B
Total BCI Market Opportunity
80M+
Stroke Survivors Worldwide
100+
Scientific Publications with CorTec Technology
70+
Research Institutes Served with CorTec Technology
